A detailed history of Engineers Gate Manager LP transactions in Abbott Laboratories stock. As of the latest transaction made, Engineers Gate Manager LP holds 97,419 shares of ABT stock, worth $10.1 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
97,419
Previous 2,538 3738.42%
Holding current value
$10.1 Million
Previous $279,000 3868.46%
% of portfolio
0.3%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $10.4 Million - $11.5 Million
94,881 Added 3738.42%
97,419 $11.1 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $1.69 Million - $2.07 Million
-18,721 Reduced 88.06%
2,538 $279,000
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $4.37 Million - $5.24 Million
-45,703 Reduced 68.25%
21,259 $2.06 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $5.99 Million - $6.68 Million
-59,451 Reduced 47.03%
66,962 $7.3 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $12 Million - $14.1 Million
123,396 Added 4090.02%
126,413 $12.8 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $2.4 Million - $2.82 Million
-25,266 Reduced 89.33%
3,017 $331,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $398,844 - $461,787
-4,122 Reduced 12.72%
28,283 $2.74 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $587,923 - $710,611
-5,760 Reduced 15.09%
32,405 $3.52 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $2.33 Million - $2.84 Million
20,412 Added 114.98%
38,165 $4.52 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $324,870 - $397,785
2,812 Added 18.82%
17,753 $2.5 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $1.53 Million - $1.69 Million
13,081 Added 703.28%
14,941 $1.77 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $3.21 Million - $3.78 Million
-30,350 Reduced 94.23%
1,860 $216,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $2.3 Million - $2.71 Million
21,170 Added 191.76%
32,210 $3.86 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $621,390 - $677,137
5,918 Added 115.54%
11,040 $1.21 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $6.43 Million - $7.81 Million
-70,170 Reduced 93.2%
5,122 $557,000
Q2 2020

Aug 17, 2020

BUY
$76.57 - $98.0 $2.66 Million - $3.4 Million
34,692 Added 85.45%
75,292 $6.88 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $2.55 Million - $3.73 Million
40,600 New
40,600 $3.2 Million
Q2 2018

Aug 03, 2018

SELL
$57.57 - $63.54 $3.8 Million - $4.2 Million
-66,060 Closed
0 $0
Q1 2018

May 07, 2018

BUY
$56.27 - $63.62 $1.63 Million - $1.85 Million
29,034 Added 78.42%
66,060 $3.96 Million
Q4 2017

Feb 01, 2018

BUY
$53.68 - $57.47 $651,675 - $697,685
12,140 Added 48.78%
37,026 $2.11 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $1.2 Million - $1.33 Million
24,886
24,886 $1.33 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.